Is Ro GLP-1 FDA Approved? The Exact Answer Before You Sign Up
Last verified: May 16, 2026 by the Weight Loss Provider Guide editorial team. We cross-referenced each medication against the FDA’s Drugs@FDA database, Ro’s public pricing and medication pages, Ro’s Terms of Use, each FDA approval letter, LillyDirect, NovoCare, TrumpRx, the CMS Medicare GLP-1 Bridge page, and independent review sources on Trustpilot, ConsumerAffairs, and the BBB.
Is Ro GLP-1 FDA approved? The short answer
Is Ro GLP-1 FDA approved? Ro itself is not FDA-approved — because the FDA approves medications, not telehealth companies. What matters is whether the specific GLP-1 medication Ro prescribes you is FDA-approved.
Ro’s public weight-loss menu currently includes several FDA-approved brand-name GLP-1 medications: Wegovy® (pen and pill), Zepbound® (pen and KwikPen®), Foundayo™ (orforglipron), Ozempic®, and Saxenda®. These are all FDA-approved drugs from Novo Nordisk or Eli Lilly. Ro’s pricing page states that cash-pay pricing on Wegovy pill, Wegovy pen, Zepbound KwikPen, and Foundayo matches the manufacturers’ direct programs (LillyDirect®, NovoCare®, and TrumpRx).
60 seconds. Ro states you’re charged the Ro Body membership only if eligible for treatment. Confirm your exact medication and route inside the intake before paying.
What we actually verified
We cross-checked Ro’s public pricing page, the Ro Body weight loss page, Ro’s Terms of Use, Ro’s medication-specific pages (Wegovy, Zepbound, Foundayo, Ozempic, Saxenda), the FDA’s Drugs@FDA approval database, the FDA approval letters for each Ro-listed product, the FDA’s compounded GLP-1 guidance pages, the LillyDirect and NovoCare pricing pages, the CMS Medicare GLP-1 Bridge page, and independent customer review sources on Trustpilot, Apple App Store, ConsumerAffairs, and the BBB.
We did not personally complete a Ro checkout in every state. Your exact medication, insurance route, prior authorization status, and final price must be confirmed inside Ro’s intake flow before you pay. Last full verification: May 16, 2026.
At a glance
| Question | Direct answer |
|---|---|
| Is Ro FDA-approved? | No. Ro is a telehealth platform. The FDA approves drugs, not companies. |
| Does Ro prescribe FDA-approved GLP-1 medications? | Yes. Ro's public menu currently lists Wegovy, Zepbound, Foundayo, Ozempic, and Saxenda. |
| Is every Ro GLP-1 option FDA-approved for weight loss? | No. Ozempic is FDA-approved for type 2 diabetes and may be prescribed off-label for weight loss. |
| Could you be prescribed a compounded (non-FDA-approved) medication? | Ro's Terms allow it during national drug shortages. Verify before paying. |
| What does Ro cost? | $39 first month + $149/month (or $74/mo annual). Medication is billed separately. |
| What's the most important thing to verify before paying? | The exact medication name on your prescription — and whether it's brand-name or compounded. |
Does FDA approval apply to Ro or to the medication?
The phrase “Is Ro GLP-1 FDA approved?” is asking the wrong question. The FDA approves drugs, not telehealth companies. So the real question is whether the specific GLP-1 medication you’ll be prescribed is FDA-approved, and what condition it’s approved to treat.
The FDA approves two things: drugs (through a New Drug Application) and medical devices. The FDA does not approve telehealth companies. It doesn’t approve Ro. It doesn’t approve Hers. It doesn’t approve your local pharmacy or your doctor’s office.
So when you Google “is Ro GLP-1 FDA approved,” the real question hiding inside it is: “Is the actual GLP-1 medication that Ro will send me an FDA-approved drug?” The answer to that depends on three things:
- Which medication the provider prescribes you
- What condition that medication is FDA-approved to treat (since “FDA-approved for diabetes” is not the same as “FDA-approved for weight loss”)
- Whether you get the brand-name FDA-approved version or — in rare cases under Ro’s Terms — a compounded version that isn’t FDA-approved
Which Ro GLP-1 medications are FDA-approved?
Every brand-name GLP-1 medication that Ro currently lists on its weight loss menu is FDA-approved. Five of them — Wegovy pen, Wegovy pill, Zepbound pen, Zepbound KwikPen, and Foundayo — are FDA-approved specifically for chronic weight management in eligible adults. Two more — Ozempic and Saxenda — are FDA-approved but used differently for weight loss (Ozempic off-label; Saxenda on-label but a first-generation option).
The Ro GLP-1 FDA Approval Matrix
| Medication on Ro | Active ingredient | Manufacturer | FDA approval date | FDA-approved to treat | On Ro? | Cash-pay price on Ro | Source verified |
|---|---|---|---|---|---|---|---|
| Wegovy® pen | Semaglutide 2.4 mg | Novo Nordisk | June 4, 2021 | Chronic weight management; CV risk reduction added 2024 | ✅ | $199 first month; $199–$399/mo after | FDA approval letter; Ro pricing; NovoCare |
| Wegovy® pill | Oral semaglutide (higher-strength) | Novo Nordisk | December 22, 2025 | Weight loss + cardiovascular risk reduction in eligible adults | ✅ NEW | $149 first month; $199–$299/mo after | FDA approval letter; Novo Nordisk announcement; Ro pricing |
| Zepbound® pen | Tirzepatide | Eli Lilly | November 8, 2023 | Chronic weight management; moderate-to-severe OSA in adults with obesity added 2024 | ✅ | Cash-pay tier; insurance route available | FDA approval letter; Ro pricing |
| Zepbound® KwikPen® | Tirzepatide | Eli Lilly | January 20, 2026 (NDA 217806/S-002) | Same as Zepbound pen | ✅ NEW | $299 (2.5 mg); $399 (5 mg); $449 (7.5–15 mg) with manufacturer offer* | FDA approval letter NDA 217806/S-002; Ro pricing |
| Foundayo™ | Orforglipron | Eli Lilly | April 1, 2026 | Chronic weight management in eligible adults | ✅ NEW | $149 first month; $199–$299/mo after with manufacturer offer† | FDA approval letter; Ro Foundayo page; LillyDirect |
| Ozempic® | Semaglutide 0.5–2.0 mg | Novo Nordisk | December 5, 2017 | Type 2 diabetes — off-label for weight loss | ✅ | ~$900–$1,100/mo cash-pay without coverage | FDA approval letter; Ro Ozempic page |
| Saxenda® | Liraglutide 3.0 mg | Novo Nordisk | December 23, 2014 | Chronic weight management in adults; also pediatric 12+ | ✅ | Varies; not in current Ro pricing grid | FDA approval letter; Ro nav |
| Compounded GLP-1 (fallback) | Compounded semaglutide/tirzepatide formulation | State-licensed 503A / FDA-registered 503B | Not FDA-approved | N/A — not an FDA-approved finished product | ⚠️ Per Terms | Cash-pay only where offered | Ro Terms of Use; Ro 2024 press release |
* Zepbound KwikPen: if the 45-day refill check-in is missed, refills may be charged at $499 (7.5 mg) or $699 (10–15 mg).
† Foundayo: if the 45-day refill check-in is missed, the highest doses may be billed at $349.
Last verified: May 16, 2026. Sources: Drugs@FDA, each medication’s FDA approval letter, Ro’s pricing and medication pages, Ro’s Terms of Use, Novo Nordisk and Eli Lilly press releases.
Ro GLP-1 FDA Approval Checker
Select the medication Ro shows you — get the FDA status, approved use, and your next step instantly.
Select a medication above to see its FDA status and next steps.
Ro GLP-1 medication deep dives
Wegovy through Ro
Wegovy is Novo Nordisk’s brand name for semaglutide approved specifically for weight management. The FDA approved Wegovy injection on June 4, 2021 for adults with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related health condition like type 2 diabetes, high blood pressure, or high cholesterol. On December 22, 2025, the FDA approved the Wegovy pill — the first semaglutide for weight loss in pill form at therapeutic strength (Rybelsus is a lower-strength pill approved for diabetes, not weight loss).
Ro carries both the Wegovy pen and the Wegovy pill. Ro’s pricing page states that cash-pay medication prices match Novo Nordisk’s direct NovoCare® pricing — meaning Ro doesn’t mark up the drug. What you pay Ro membership for is the clinical wrap-around, not the medication itself.
Zepbound through Ro
Zepbound is Eli Lilly’s brand name for tirzepatide approved for weight loss. The original Zepbound single-dose pen was FDA-approved on November 8, 2023 for chronic weight management. In 2024, the FDA added a second approved use: moderate-to-severe obstructive sleep apnea in adults with obesity.
The newer Zepbound KwikPen® — a multi-dose pen format — was approved by the FDA via supplemental NDA 217806/S-002, with the approval letter dated January 20, 2026. It’s a separate presentation of the same tirzepatide molecule, designed for easier administration over multiple doses.
In its pivotal trial (SURMOUNT-1), the highest dose of tirzepatide produced average weight reductions reported around 20.9% over 72 weeks — the largest weight-loss effect of any FDA-approved GLP-1 weight management medication on the U.S. market as of this verification. Your individual results will vary. Ro carries both the original Zepbound pen and the Zepbound KwikPen through LillyDirect®.
Foundayo through Ro
Foundayo (orforglipron) is the newest weight-loss GLP-1 — and the only daily oral GLP-1 that doesn’t require fasting before or after taking it. The FDA approved Foundayo on April 1, 2026 for chronic weight management in adults with obesity or overweight plus a weight-related condition.
If you’ve been considering a GLP-1 but don’t want to inject yourself weekly, Foundayo is the option that didn’t exist a year ago. Ro added it to its menu shortly after FDA approval. The cash-pay price matches LillyDirect at $149 for the first month and $199–$299/month thereafter — with one condition: if you miss the 45-day refill check-in, the highest doses may be billed at $349.
Ozempic through Ro
The FDA approved Ozempic on December 5, 2017 for type 2 diabetes. Ro’s own page states that Ro-affiliated providers may prescribe Ozempic off-label for weight loss when they determine it’s medically appropriate. Off-label prescribing is legal and common in U.S. medicine — about 1 in 5 prescriptions is off-label — but it’s a different regulatory category.
If your insurance only covers GLP-1s with a weight-loss indication, Ozempic typically won’t be covered for weight loss. If you specifically want a medication FDA-approved on the weight-loss label, ask Ro about Wegovy, Zepbound, or Foundayo instead.
Saxenda through Ro
Saxenda is liraglutide — the original FDA-approved daily-injection GLP-1 for weight loss, approved on December 23, 2014. It’s still in Ro’s weight-loss navigation and still FDA-approved for chronic weight management (adults and pediatric patients 12+). The honest tradeoff: liraglutide is a first-generation GLP-1, and newer drugs like semaglutide (Wegovy) and tirzepatide (Zepbound) generally produced larger average weight reductions in their pivotal trials. If you need a daily injection for medical reasons, Saxenda is a real option. For most readers, Ro will steer toward Wegovy, Zepbound, or Foundayo.
See if your insurance covers an FDA-approved GLP-1 through Ro →Ro’s free insurance checker is a coverage estimate — prior authorization and your plan’s specific formulary rules determine final coverage.
Does Ro prescribe compounded GLP-1 medication?
Ro’s Terms of Use state that members may be prescribed compounded medication during national drug shortages. Compounded medications are not FDA-approved finished products. Ro’s primary path is brand-name FDA-approved medication, but the compounded clause is real — and you should know how to spot this before you pay.
In a 2024 press release announcing its GLP-1 Supply Tracker, Ro publicly acknowledged: “Ro also offers compounded GLP-1s to help maintain patients’ access to treatment and continuity of care during the shortage of branded GLP-1s.” That’s a direct, verifiable statement from Ro itself.
A compounded medication is a custom-prepared drug made by a state-licensed (503A) compounding pharmacy or an FDA-registered (503B) outsourcing facility. Compounding pharmacies have a legitimate role in medicine — they make medications for patients with specific allergies, dose needs, or when an FDA-approved product is in shortage. But compounded products are not FDA-approved finished drug products. The FDA does not review compounded medications for safety, effectiveness, or quality before they’re marketed.
The FDA officially declared the semaglutide shortage resolved in February 2025, with deadlines in April and May 2025 for compounding pharmacies to wind down semaglutide compounding. The tirzepatide shortage was resolved earlier. For Ro specifically: Ro’s primary path is brand-name FDA-approved medication. The compounded clause exists and you should know what it means.
The exact question to ask Ro before paying:
“Will my prescription be for a brand-name FDA-approved medication — Wegovy, Zepbound, Foundayo, or Ozempic — or will it be a compounded medication?”
Is Ozempic from Ro FDA-approved for weight loss?
No. Ozempic is FDA-approved for type 2 diabetes, not weight loss. Ro states that Ro-affiliated providers may prescribe Ozempic off-label for weight loss when they determine it’s appropriate. The medication itself is FDA-approved. The weight-loss use is off-label.
This distinction matters in three real-world situations:
1. Insurance coverage
Many commercial insurance plans cover Ozempic only with a documented type 2 diabetes diagnosis. If you don’t have diabetes, your plan will likely deny coverage for Ozempic prescribed for weight loss. Wegovy, Zepbound, and Foundayo have weight-loss indications and are more often covered for weight loss under commercial plans.
2. Label warnings
When a drug is prescribed on-label, the FDA-approved prescribing information was written for that exact use. When it’s prescribed off-label, you’re using the drug at the provider’s discretion based on related clinical evidence — which can be excellent, but is a different legal and regulatory category.
3. Long-term supply
Ozempic is in higher demand for diabetes patients than for weight-loss patients, and pharmacies sometimes prioritize on-label diabetes prescriptions during constrained supply.
If you specifically want a medication that’s FDA-approved on the weight-loss label, the simple rule is: ask Ro for Wegovy, Zepbound, or Foundayo — not Ozempic. All three are widely available through Ro and all three are FDA-approved on the weight-loss label.
How much does Ro GLP-1 cost?
Ro Body membership is $39 for the first month, then $149/month — or as low as $74/month if you prepay an annual plan. Medication is billed separately on top of that. The $39 intro price is the membership fee only — not your total cost of GLP-1 treatment.
The two-part Ro bill
| Cost | What it is | What Ro publishes |
|---|---|---|
| Ro Body membership | Platform access, clinical care, app, lab work, weekly coaching, insurance support | $39 first month, then $149/month (or $74/mo on an annual plan paid upfront). Charged only if eligible for treatment. |
| Your medication | The actual GLP-1 drug | Billed separately each month at cash-pay or insurance copay |
Medication prices through Ro
Ro’s pricing page states cash-pay medication prices for Wegovy pill, Wegovy pen, Zepbound KwikPen, and Foundayo match the manufacturers’ direct programs. Ro doesn’t mark up the drug.
| Medication | First-month cash-pay | Ongoing cash-pay | Important condition |
|---|---|---|---|
| Wegovy pill | $149 | $199–$299 (varies by dose) | — |
| Foundayo | $149 | $199–$299 (varies by dose) | If you miss the 45-day refill check-in, highest doses may be billed at $349 |
| Wegovy pen | $199 | $199–$399 (varies by dose) | — |
| Zepbound KwikPen | $299 (2.5 mg); $399 (5 mg); $449 (7.5–15 mg) | Same | If you miss the 45-day refill check-in: $499 (7.5 mg) or $699 (10–15 mg) |
| Ozempic | Varies | ~$900–$1,100/mo cash-pay without coverage | Insurance copay varies if covered for T2D |
Membership ($39/$149/$74/mo) is billed separately from medication. All prices verified May 16, 2026 from Ro’s public pricing page.
How does Ro’s GLP-1 program work? (Step by step)
Ro’s process is fully online: you complete an intake questionnaire, a licensed provider reviews it, you get a prescription if you qualify, the medication is fulfilled through the appropriate pharmacy route, and ongoing care happens through the Ro app. Most patients get a clinical decision within a couple of days; insurance-routed prescriptions can take 2–3 weeks to fully process.
Online intake
You fill out a detailed medical questionnaire — weight, height, medical history, current medications, weight-related conditions, allergies, family history (including thyroid cancer history, which is a hard contraindication for GLP-1s). You upload a photo ID. This step usually takes 10–15 minutes.
Licensed provider review
A licensed clinician — physician, nurse practitioner, or physician assistant, depending on the state requirements where you live — reviews your intake. They may message you with follow-up questions or order baseline labs. Some states require synchronous video visits; many use asynchronous messaging. If you qualify, the provider writes a prescription. If you don't, they tell you why.
Insurance or cash-pay routing
If you opted to use insurance, Ro's insurance team contacts your plan, verifies coverage, and starts the prior authorization process if your plan requires one. PA typically takes 2–3 weeks. If you opted for cash-pay, your prescription is routed to the appropriate fulfillment.
Medication fulfillment
Cash-pay Wegovy pill, Wegovy pen, Foundayo, and Zepbound KwikPen typically ship directly. Ozempic and insurance-routed GLP-1s are typically picked up and paid for at your pharmacy. Confirm your exact fulfillment route during intake.
Ongoing care
Once on medication, you use the Ro app for weekly nurse coaching messages, provider check-ins, dose adjustments, side effect management, lab work at Quest Diagnostics (included in membership), and reordering refills. Mind the 45-day refill check-in for Foundayo and Zepbound KwikPen.
Can you cancel Ro Body?
Yes, you can cancel Ro Body anytime through your account settings. Ro requires cancellation at least 48 hours before your renewal date, the membership fee is non-refundable once paid, and prescription medication you’ve already received generally cannot be returned or refunded.
How to cancel (the actual steps)
- Log into your Ro account
- Open the Ro Body Program card
- Click “Plan”
- Select “Cancel Plan”
- If the cancellation option isn’t visible, message Ro support directly
The 48-hour rule
If your renewal date is the 15th of the month, you must cancel by the 13th to avoid being charged for the next month. People who try to cancel the day before their renewal sometimes get hit with the next month’s charge. Mark your renewal date on your calendar two business days early.
What’s not refundable
Per Ro’s Terms of Use: the Ro Body Program membership fee is non-refundable once paid, and prescription products generally cannot be returned or refunded once dispensed. This is standard for prescription medication across the telehealth industry. When you cancel, take screenshots of the confirmation page — if you ever need to dispute a charge, that screenshot is your evidence.
The honest drawbacks of Ro (we’re not hiding these)
Drawback #1: Ro is not the cheapest path to GLP-1 access
If your only priority is the lowest monthly cost and you’re willing to take compounded medication, dedicated compounded providers will be cheaper than Ro. Eden, MEDVi, and others have all-in monthly prices below Ro’s stacked membership-plus-medication math.
But here’s the pivot: Ro is not built to be the cheapest. Ro is built to deliver brand-name FDA-approved medication with insurance support and clinical wrap-around. If your insurance covers Wegovy or Zepbound at a $50 copay, Ro becomes the cheapest legitimate path in the brand-name lane — because the membership fee is what unlocks the insurance work that drops your medication cost from $400/month to $50/month.
Drawback #2: The two-part pricing confuses people
This is the single most common complaint. People see “$39 first month” in the ad and don’t realize that’s the membership fee only — not the medication. Then their second statement arrives with the medication charge on top and they feel misled. Ro could do a clearer job in their checkout flow. Until they do, just remember: $39 is membership, not your total. Use the pricing table above to estimate your actual monthly spend.
Drawback #3: No Medicare, Medicaid, or TRICARE (FEHB members excepted)
If you have Medicare, Medicaid, or TRICARE, Ro can’t coordinate your coverage for the Body Program. The Medicare GLP-1 Bridge program (launching July 1, 2026) is the path for eligible Medicare Part D patients. Medicaid varies by state. FEHB members are an exception — Ro states FEHB members can use Ro Body and the insurance team.
Drawback #4: No HSA or FSA at checkout
Ro does not currently accept HSA or FSA cards for payment at checkout. If you rely on those accounts for medical expenses, you’ll need a provider that accepts them, or you’ll need to pay out-of-pocket and try to manually submit receipts for reimbursement — which may or may not work depending on your plan administrator.
What to verify before you pay (the 12-point checklist)
You don’t have to guess. Before you click through Ro’s final payment screen, verify these twelve things. If any are unclear, pause — get the answer from Ro’s intake flow or support chat — and only then continue. This is how you avoid every common Ro complaint.
We built this checklist after reviewing recurring complaint patterns across Trustpilot, ConsumerAffairs, and BBB as of May 16, 2026. Almost every common complaint we read would have been prevented by one of these twelve confirmations.
The Ro Pre-Payment Checklist
0/12 verifiedCheck each item as you confirm it inside Ro’s intake. If anything is unclear, pause and ask before paying.
- 1. Exact medication name on your prescription. Wegovy, Zepbound, Foundayo, Ozempic, Saxenda — or compounded? Get the specific name.
- 2. Brand-name FDA-approved finished product, or compounded medication. Ask directly.
- 3. The FDA-approved use for that specific medication. Is your prescription on-label or off-label for weight loss?
- 4. First-month total cost. Membership + medication, all in.
- 5. Ongoing monthly total cost. Same calculation, for month 2+.
- 6. Whether the ongoing medication price is at your starting dose or your maintenance dose. Maintenance doses are usually more expensive. Confirm the 45-day refill check-in requirement on Foundayo and Zepbound KwikPen if applicable.
- 7. Insurance or cash-pay route. Which path is yours, and what's the actual copay if insurance is involved?
- 8. Renewal date for your Ro Body membership. Mark it on your calendar.
- 9. Cancellation deadline. Ro requires at least 48 hours before renewal. Know the exact day.
- 10. Membership refund rules and prescription refund policy. Ro's Terms state the Ro Body membership fee is non-refundable once paid; prescription medication that has been dispensed is generally not refundable. Confirm both.
- 11. Pharmacy or fulfillment route. Brand-name cash-pay medications like Wegovy pill, Wegovy pen, Foundayo, and Zepbound KwikPen typically ship directly. Ozempic and insurance-routed prescriptions are typically picked up and paid for at your pharmacy. Confirm yours.
- 12. What happens if insurance denies coverage. Ro will often suggest a cash-pay alternative — you should know what that alternative is before you're in a corner.
Charged only if eligible. Use the 12-point checklist as you go. If anything’s unclear, ask before paying.
What are the best FDA-approved alternatives to Ro?
If Ro turns out not to be your fit and you specifically want FDA-approved brand-name GLP-1 medication, the strongest alternatives are Sesame Care (broad brand-name access with Costco-member pricing on certain medications), Hers (female-coded mainstream brand with FDA-approved Wegovy and Ozempic after the March 2026 Novo Nordisk partnership), and Hims (male-coded mainstream brand with the same Novo formulary).
| Alternative | Verified differentiator | Honest tradeoff vs Ro |
|---|---|---|
| Sesame Care | Per-visit model rather than a subscription. Publicly lists Wegovy pill, Zepbound KwikPen, Wegovy pen, Foundayo, and tirzepatide access; also publishes Costco-member pricing on certain GLP-1s. | No dedicated insurance team fighting for coverage the way Ro has. |
| Hers (female-coded) | Following the March 2026 Novo Nordisk partnership, Hers offers FDA-approved Wegovy pen, Wegovy pill, and Ozempic. | Narrower formulary (no Zepbound, no Foundayo as of this verification). Insurance support less robust than Ro’s. |
| Hims (male-coded) | Same March 2026 Novo Nordisk partnership as Hers. FDA-approved Wegovy and Ozempic access. | Same tradeoffs as Hers. |
Date checked: May 16, 2026. Verify Mounjaro, Saxenda, or other specific medication availability directly with each provider before signing up.
Final verdict — should you use Ro?
Use Ro if you want FDA-approved brand-name GLP-1 medication, you have commercial or FEHB insurance that might cover it (or you’re paying cash and you want manufacturer-direct pricing without finding your own prescriber), and you’re comfortable paying a separate membership for clinical support and insurance work.
✅ Use Ro if all of these are true:
- ✓You want brand-name FDA-approved GLP-1 medication (Wegovy, Zepbound, Foundayo, Ozempic, or Saxenda)
- ✓You have commercial insurance or FEHB you'd like to use, or you accept cash-pay at manufacturer-direct prices
- ✓You're comfortable with a virtual-only clinical experience
- ✓You're willing to pay $39/$149/$74 membership separately from the medication
- ✓You'll verify the exact prescription before paying
❌ Wait or pick elsewhere if any of these apply:
- ✕The medication shown at checkout isn't brand-name (or isn't clear)
- ✕The total cost shown excludes a fee you can't account for
- ✕You only want FDA-approved-for-weight-loss medication and Ro shows you Ozempic without explaining off-label use
- ✕You're being offered compounded medication and you don't want compounded
- ✕You have Medicare, Medicaid, or TRICARE (other than FEHB)
The quiz asks about your insurance, budget, medication preference, and state, then routes you to the program that actually fits. No charge. No commitment.
Frequently asked questions
Is Ro GLP-1 FDA approved?
Ro itself is not FDA-approved because the FDA approves medications, not telehealth platforms. Ro currently lists access to several FDA-approved brand-name GLP-1 medications — including Wegovy, Zepbound, Foundayo, Ozempic, and Saxenda — but the answer depends on the exact medication prescribed. Ro's Terms also allow compounded medication during national drug shortages, so verify your specific prescription before paying.
Does Ro prescribe compounded GLP-1 medication?
Ro's Terms of Use state that members may be prescribed compounded medication during national drug shortages. Ro's primary path is brand-name FDA-approved medication, but if FDA approval is essential, ask Ro directly at intake whether your prescription will be brand-name or compounded.
Is Ozempic from Ro FDA-approved for weight loss?
No. Ozempic is FDA-approved for type 2 diabetes, not weight loss. Ro states that Ozempic may be prescribed off-label for weight loss when a provider determines it's appropriate. The drug itself is FDA-approved; the weight-loss use is off-label.
How much does Ro GLP-1 cost?
Ro Body membership is $39 for the first month, then $149 per month — or as low as $74 per month with an annual plan paid upfront. Medication is billed separately. Cash-pay medication prices on Wegovy pill, Wegovy pen, Zepbound KwikPen, and Foundayo match manufacturer-direct pricing; insurance copays vary by plan.
Does Ro offer Foundayo?
Yes. Foundayo (orforglipron) was FDA-approved on April 1, 2026, and Ro added it to its menu shortly after. Ro's Foundayo pricing is $149 first month and $199–$299/month after, depending on dose, with the highest doses potentially billed at $349 if the 45-day refill check-in is missed.
Can I use Ro if I have Medicare or Medicaid?
Not through the Ro Body Program. Ro currently can't coordinate GLP-1 medication coverage for Medicare, Medicaid, or TRICARE, though FEHB members are an exception. Medicare beneficiaries should evaluate the Medicare GLP-1 Bridge demonstration program scheduled to run July 1, 2026 through December 31, 2027.
Can I cancel Ro Body?
Yes. Cancel through your account's plan settings. Ro requires cancellation at least 48 hours before your next renewal date to avoid being charged for the next month. Per Ro's Terms, the Ro Body Program membership fee is non-refundable once paid. Prescription medication that has been dispensed is generally not refundable.
How we built this page
We’re an independent comparison resource for GLP-1 telehealth providers. We earn commissions when readers visit Ro and other providers through our links — and we never recommend a provider that fails our verification standards.
- —Cross-referenced each medication on Ro's weight-loss menu against the FDA's Drugs@FDA approval database and each medication's FDA approval letter to confirm approval dates and indications
- —Pulled current pricing directly from ro.co/weight-loss/pricing and the Ro Foundayo and Zepbound pages as of May 16, 2026
- —Reviewed Ro's Terms of Use for the compounded-medication clause, government-insurance limitations, FEHB exception, and membership refund rules
- —Cross-checked Ro's medication cash-pay prices against LillyDirect.com and NovoCare.com for the matching products
- —Reviewed FDA guidance on compounded GLP-1 medications, including the 2025 shortage resolution and subsequent enforcement updates
- —Reviewed the CMS Medicare GLP-1 Bridge page for current eligibility, covered medications, and copay terms
- —Reviewed independent customer reviews on Trustpilot, Apple App Store, ConsumerAffairs, and the BBB for customer-experience signal
Last verified: May 16, 2026. Next scheduled re-verification: August 2026, or sooner if Ro changes its menu, pricing, or Terms, or if the FDA approves a new GLP-1.